| Drug resistance in cancer: an overview G Housman, S Byler, S Heerboth, K Lapinska, M Longacre, N Snyder, ... Cancers 6 (3), 1769-1792, 2014 | 2570 | 2014 |
| EMT and tumor metastasis S Heerboth, G Housman, M Leary, M Longacre, S Byler, K Lapinska, ... Clinical and translational medicine 4 (1), 6, 2015 | 840 | 2015 |
| Use of epigenetic drugs in disease: an overview S Heerboth, K Lapinska, N Snyder, M Leary, S Rollinson, S Sarkar Genetics & epigenetics 6, GEG. S12270, 2014 | 362 | 2014 |
| Genetic and epigenetic aspects of breast cancer progression and therapy S Byler, S Goldgar, S Heerboth, M Leary, G Housman, K Moulton, ... Anticancer research 34 (3), 1071-1077, 2014 | 264 | 2014 |
| The evolution of epigenetics: from prokaryotes to humans and its biological consequences A Willbanks, M Leary, M Greenshields, C Tyminski, S Heerboth, ... Genetics & epigenetics 8, GEG. S31863, 2016 | 90 | 2016 |
| Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy S Sarkar, S Goldgar, S Byler, S Rosenthal, S Heerboth Epigenomics 5 (1), 87-94, 2013 | 84 | 2013 |
| A comparative analysis of genetic and epigenetic events of breast and ovarian cancer related to tumorigenesis M Longacre, NA Snyder, G Housman, M Leary, K Lapinska, S Heerboth, ... International journal of molecular sciences 17 (5), 759, 2016 | 66 | 2016 |
| Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor MA Mataga, S Rosenthal, S Heerboth, A Devalapalli, S Kokolus, ... Anticancer research 32 (7), 2523-2529, 2012 | 60 | 2012 |
| Cancer Progenitor Cells: The Result of an Epigenetic Event? K LAPINSKA, G FARIA, S MCGONAGLE, KM MACUMBER, S HEERBOTH, ... Anticancer research 38 (1), 1-6, 2018 | 25 | 2018 |
| The effects of histone deacetylase inhibitor and calpain inhibitor combination therapies on ovarian cancer cells K Lapinska, G Housman, S Byler, S Heerboth, A Willbanks, A Oza, ... Anticancer research 36 (11), 5731-5742, 2016 | 23 | 2016 |
| Histone deacetylases (HDACs): Function, mechanism, & inhibition S Sarkar, M Longacre, N Tatur, S Heerboth, K Lapinska Encyclopedia of Analytical Chemistry: Applications, Theory and …, 2006 | 14 | 2006 |
| N- and C-terminal non-conserved residues contribute to transactivation by a sea anemone (Nematostella vectensis) NF-κB transcription factor A Alshanbayeva, A Thomas, M Tremblay, M Abbas, F Abdurrob, T Almojel, ... Bios 86 (4), 165-175, 2015 | 2 | 2015 |
| Anticancer effects of histone deacetylase inhibitors and calpain inhibitor K Lapinska, G Housman, S Heerboth, M Longacre, S Sarkar INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 32, S16-S16, 2013 | 1 | 2013 |
| Epigenetic regulation of tumor suppressor genes including imprinted gene ARHI and micro-RNAs in cancer cells S Byler, S Goldgar, S Heerboth, S Rosenthal, S Kokolus, S Sarkar INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 32, S15-S15, 2013 | | 2013 |
| Mechanism of DNMT1 downregulation in the demethylation and reexpression of tumor suppressor genes S Heerboth, S Rosenthal, N Tatur, K Lapinska, S Kokolus, S Sarkar INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 32, S16-S16, 2013 | | 2013 |
| The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells: Beyond the Abstract K Lapinska, G Housman, S Byler, S Heerboth, S Sarkar | | |
| Epigenetic Regulation of microRNA Expression in Breast and Ovarian Cancer Cells K Moulton, S Heerboth, A Oza, G Horn, S Byler, S Sarkar | | |
